|
1
|
Ekbom A, Helmick C, Zack M and Adami HO:
Increased risk of large-bowel cancer in Crohn’s disease with
colonic involvement. Lancet. 336:357–359. 1990.
|
|
2
|
Ekbom A, Helmick C, Zack M and Adami HO:
Ulcerative colitis and colorectal cancer. A population-based study.
N Engl J Med. 323:1228–1233. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brentnall TA: Risk factors for development
of colorectal cancer in inflammatory bowel disease. Advances in
Inflammatory Bowel Disease. Norwell M: Kluwer Academic Publishers;
Norwell, MA: pp. 159–167. 1998
|
|
4
|
Brentnall TA, Crispin DA, Rabinovitch PS,
Haggitt RC, Rubin CE, Stevens AC and Burmer GC: Mutations in the
p53 gene: an early marker of neoplastic progression in ulcerative
colitis. Gastroenterology. 107:369–378. 1994.PubMed/NCBI
|
|
5
|
Rabinovitch PS, Dziadon S, Brentnall TA,
Emond MJ, Crispin DA, Haggitt RC and Bronner MP: Pancolonic
chromosomal instability precedes dysplasia and cancer in ulcerative
colitis. Cancer Res. 59:5148–5153. 1999.PubMed/NCBI
|
|
6
|
Harpaz N and Talbot IC: Colorectal cancer
in idiopathic inflammatory bowel disease. Semin Diagn Pathol.
13:339–357. 1996.PubMed/NCBI
|
|
7
|
Eaden JA, Abrams KR and Mayberry JF: The
risk of colorectal cancer in ulcerative colitis: a meta-analysis.
Gut. 48:526–535. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rutter MD, Saunders BP, Wilkinson KH,
Rumbles S, Schofield G, Kamm MA, Williams CB, Price AB, Talbot IC
and Forbes A: Thirty-year analysis of a colonoscopic surveillance
program for neoplasia in ulcerative colitis. Gastroenterology.
130:1030–1038. 2006.PubMed/NCBI
|
|
9
|
Riddell RH, Goldman H, Ransohoff DF,
Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton
SR, Morson BC, Sommers SC and Yardley JH: Dysplasia in inflammtory
bowel disease: standardized classification with provisional
clinical applications. Hum Pathol. 14:931–968. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
11
|
Esteller M: Epigenetic gene silencing in
cancer: the DNA hypermethylome. Hum Mol Genet. 16:R50–R59. 2007.
View Article : Google Scholar
|
|
12
|
Tominaga K, Fujii S, Mukawa K, Fujita M,
Ichikawa K, Tomita S, Imai Y, Kanke K, Ono Y, Terano A, Hiraishi H
and Fujimori T: Prediction of colorectal neoplasia by quantitative
methylation analysis of estrogen receptor gene in nonneoplastic
epithelium from patients with ulcerative colitis. Clin Cancer Res.
11:8880–8885. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sato F, Shibata D, Harpaz N, Xu Y, Yin J,
Mori Y, Wang S, Olaru A, Deacu E, Selaru FM, Kimos MC, Hytiroglou
P, et al: Aberrant methylation of the HPP1 gene in ulcerative
colitis-associated colorectal carcinoma. Cancer Res. 62:6820–6822.
2002.PubMed/NCBI
|
|
14
|
Maekita T, Nakazawa K, Mihara M, Nakajima
T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M,
Tamura G, Saito D, et al: High levels of aberrant DNA methylation
in Helicobacter pylori-infected gastric mucosae and its
possible association with gastric cancer risk. Clin Cancer Res.
12:989–995. 2006.PubMed/NCBI
|
|
15
|
Nakajima T, Enomoto S, Yamashita S, Ando
T, Nakanishi Y, Nakazawa K, Oda I, Gotoda T and Ushijima T:
Persistence of a component of DNA methylation in gastric mucosae
after Helicobacter pylori eradication. J Gastroenterol.
45:37–44. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki H, Watkins DN, Jair KW, Schuebel
KE, Markowitz SD, Chen WD, Pretlow TP, Yang B, Akiyama Y, Van
Engeland M, Toyota M, Tokino T, et al: Epigenetic inactivation of
SFRP genes allows constitutive WNT signaling in colorectal cancer.
Nat Genet. 36:417–422. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schuebel KE, Chen W, Cope L, Glöckner SC,
Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den
Bosch S, van Engeland M, Ting AH, et al: Comparing the DNA
hypermethylome with gene mutations in human colorectal cancer. PLoS
Genet. 3:1709–1723. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Glöckner SC, Dhir M, Yi JM, McGarvey KE,
Van Neste L, Louwagie J, Chan TA, Kleeberger W, de Bruïne AP, Smits
KM, Khalid-de Bakker CA, Jonkers DM, et al: Methylation of TFPI2 in
stool DNA: a potential novel biomarker for the detection of
colorectal cancer. Cancer Res. 69:4691–4699. 2009.PubMed/NCBI
|
|
19
|
Yi JM, Dhir M, Van Neste L, Downing SR,
Jeschke J, Glöckner SC, de Freitas Calmon M, Hooker CM, Funes JM,
Boshoff C, Smits KM, van Engeland M, et al: Genomic and epigenomic
integration identifies a prognostic signature in colon cancer. Clin
Cancer Res. 17:1535–1545. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Podolsky DK: Inflammatory bowel disease
(1). N Engl J Med. 325:928–937. 1991. View Article : Google Scholar
|
|
21
|
Langholz E, Munkholm P, Davidsen M and
Binder V: Course of ulcerative colitis: analysis of changes in
disease activity over years. Gastroenterology. 107:3–11.
1994.PubMed/NCBI
|
|
22
|
Herman JG, Graff JR, Myohanen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rhee I, Bachman KE, Park BH, Jair KW, Yen
RW, Schuebel KE, Cui H, Feinberg AP, Lengauer C, Kinzler KW, Baylin
SB and Vogelstein B: DNMT1 and DNMT3b cooperate to silence genes in
human cancer cells. Nature. 416:552–556. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fleisher AS, Esteller M, Harpaz N, Leytin
A, Rashid A, Xu Y, Liang J, Stine OC, Yin J, Zou TT, Abraham JM,
Kong D, et al: Microsatellite instability in inflammatory bowel
disease-associated neoplastic lesions is associated with
hypermethylation and diminished expression of the DNA mismatch
repair gene, hMLH1. Cancer Res. 60:4864–4868. 2000.
|
|
25
|
Issa JP, Ahuja N, Toyota M, Bronner MP and
Brentnall TA: Accelerated age-related CpG island methylation in
ulcerative colitis. Cancer Res. 61:3573–3577. 2001.PubMed/NCBI
|
|
26
|
Sato F, Harpaz N, Shibata D, Xu Y, Yin J,
Mori Y, Zou TT, Wang S, Desai K, Leytin A, Selaru FM, Abraham JM
and Meltzer SJ: Hypermethylation of the p14(ARF) gene in ulcerative
colitis-associated colorectal carcinogenesis. Cancer Res.
62:1148–1151. 2002.PubMed/NCBI
|
|
27
|
Fujii S, Tominaga K, Kitajima K, Takeda J,
Kusaka T, Fujita M, Ichikawa K, Tomita S, Ohkura Y, Ono Y, Imura J,
Chiba T and Fujimori T: Methylation of the oestrogen receptor gene
in non-neoplastic epithelium as a marker of colorectal neoplasia
risk in longstanding and extensive ulcerative colitis. Gut.
54:1287–1292. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang FY, Arisawa T, Tahara T, Takahama K,
Watanabe M, Hirata I and Nakano H: Aberrant DNA methylation in
ulcerative colitis without neoplasia. Hepatogastroenterology.
55:62–65. 2008.PubMed/NCBI
|
|
29
|
Lin Z, Hegarty JP, Cappel JA, Yu W, Chen
X, Faber P, Wang Y, Kelly AA, Poritz LS, Peterson BZ, Schreiber S,
Fan JB and Koltun WA: Identification of disease-associated DNA
methylation in intestinal tissues from patients with inflammatory
bowel disease. Clin Genet. 80:59–67. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Saito S, Kato J, Hiraoka S, Horii J,
Suzuki H, Higashi R, Kaji E, Kondo Y and Yamamoto K: DNA
methylation of colon mucosa in ulcerative colitis patients:
correlation with inflammatory status. Inflamm Bowel Dis.
17:1955–1965. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yi JM, Dhir M, Guzzetta AA,
Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM
and Ahuja N: DNA methylation biomarker candidates for early
detection of colon cancer. Tumor Biol. 33:363–372. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suzuki H, Gabrielson E, Chen W, Anbazhagan
R, van Engeland M, Weijenberg MP, Herman JG and Baylin SB: A
genomic screen for genes upregulated by demethylation and histone
deacetylase inhibition in human colorectal cancer. Nat Genet.
31:141–149. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Stoehr R, Wissmann C, Suzuki H, Knuechel
R, Krieg RC, Klopocki E, Dahl E, Wild P, Blaszyk H, Sauter G, Simon
R, Schmitt R, et al: Deletions of chromosome 8p and loss of sFRP1
expression are progression markers of papillary bladder cancer. Lab
Invest. 84:465–478. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lodygin D, Epanchintsev A, Menssen A,
Diebold J and Hermeking H: Functional epigenomics identifies genes
frequently silenced in prostate cancer. Cancer Res. 65:4218–4227.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fukui T, Kondo M, Ito G, Maeda O, Sato N,
Yoshioka H, Yokoi K, Ueda Y, Shimokata K and Sekido Y:
Transcriptional silencing of secreted frizzled related protein 1
(SFRP1) by promoter hypermethylation in non-small-cell lung cancer.
Oncogene. 24:6323–6327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suzuki H, Toyota M, Carraway H, Gabrielson
E, Ohmura T, Fujikane T, Nishikawa N, Sogabe Y, Nojima M, Sonoda T,
Mori M, Hirata K, et al: Frequent epigenetic inactivation of Wnt
antagonist genes in breast cancer. Br J Cancer. 98:1147–1156. 2008.
View Article : Google Scholar : PubMed/NCBI
|
